Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$11.25 - $14.75 $35,516 - $46,565
-3,157 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$10.69 - $16.49 $3,068 - $4,732
287 Added 10.0%
3,157 $36,000
Q1 2020

May 12, 2020

BUY
$9.78 - $29.53 $7,784 - $23,505
796 Added 38.38%
2,870 $41,000
Q4 2019

Feb 06, 2020

SELL
$20.93 - $35.1 $4 Million - $6.71 Million
-191,088 Reduced 98.93%
2,074 $56,000
Q3 2019

Nov 13, 2019

BUY
$22.08 - $47.08 $345,861 - $737,461
15,664 Added 8.82%
193,162 $5.53 Million
Q2 2019

Aug 12, 2019

BUY
$22.67 - $35.0 $799,502 - $1.23 Million
35,267 Added 24.8%
177,498 $4.93 Million
Q1 2019

May 09, 2019

BUY
$26.93 - $34.7 $3.53 Million - $4.55 Million
131,246 Added 1194.77%
142,231 $4.72 Million
Q4 2018

Feb 11, 2019

SELL
$27.23 - $45.56 $1.55 Million - $2.59 Million
-56,788 Reduced 83.79%
10,985 $319,000
Q3 2018

Nov 13, 2018

BUY
$37.57 - $50.34 $8,453 - $11,326
225 Added 0.33%
67,773 $3.12 Million
Q2 2018

Aug 09, 2018

BUY
$27.75 - $40.17 $3,219 - $4,659
116 Added 0.17%
67,548 $2.52 Million
Q1 2018

May 14, 2018

BUY
$28.83 - $41.01 $1.15 Million - $1.64 Million
40,043 Added 146.2%
67,432 $1.99 Million
Q4 2017

Feb 09, 2018

BUY
$28.45 - $37.14 $967 - $1,262
34 Added 0.12%
27,389 $941,000
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $656,793 - $990,251
27,355
27,355 $990,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.2B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.